In this newsletter, we provide information about a survey of Latvian residents conducted by the Latvian Medicines Verification Organisation and the research centre SKDS – including its objectives, results, and conclusions.
We also invite you to review the first-quarter performance indicators of LZVS, as well as the new LZVS connection addresses.
For more details on all current updates and events, we encourage you to read the April edition of the newsletter.